COL7A1 and Dystrophic epidermolysis bullosa: Moreover, at least 774 mutations within COL7A1 have been reported in different variants of dystrophic epidermolysis bullosa [4], which makes it necessary to develop customized gene editing therapies for each patient, which is time-consuming and expensive.